FDA reports Samsca may cause liver damage
(HealthDay)—After reviewing data from recent large clinical trials, the U.S. Food and Drug Administration has determined that Samsca (tolvaptan) should not be used for longer than 30 days and should not ...
Medications
May 02, 2013 |
not rated yet |
0
Nephrologist follow-up improves mortality of severe acute kidney injury patients
Patients with acute kidney injury who see a nephrologist within 90 days of being discharged from a hospital have a 24 per cent lower risk of dying than those who do not see a kidney specialist, a new study has found.
Diseases, Conditions, Syndromes
Apr 30, 2013 |
5 / 5 (1) |
0
Prophylactic sodium bicarbonate infusion and acute kidney injury after open heart surgery
Contrary to the positive findings of a previous pilot study, administration of a sodium bicarbonate-based infusion to induce urinary alkalinization during and after surgery does not reduce the incidence of acute kidney injury ...
Cardiology
Apr 16, 2013 |
not rated yet |
0
High potency statins pose significantly higher risk of kidney injury than low potency, say experts
Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalised for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today in BMJ sugges ...
Cardiology
Mar 19, 2013 |
5 / 5 (1) |
1
Potential early indicator of kidney injury identified
A guidance cue that helps kidneys form may also be a red flag that they are in danger, researchers report.
Diseases, Conditions, Syndromes
Mar 12, 2013 |
not rated yet |
0
|
Drug protects against kidney injury from imaging dye in ACS patients
High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research ...
Cardiology
Mar 11, 2013 |
not rated yet |
0
Antibody response linked with rejection in pediatric kidney transplant recipients
A transplanted kidney has a finite life expectancy because it often becomes the target of the recipient's immune system, which may mount antibodies that attack the organ. Because there is a critical need to extend the life ...
Other
Feb 28, 2013 |
not rated yet |
0
Sodium transporter appears likely target for treating salt-sensitive hypertension
Genetics and demographics likely put you at risk for salt-sensitive hypertension, and scientists are looking for a way to protect you.
Medical research
Feb 26, 2013 |
4.5 / 5 (2) |
0
|
Certain mutations affect kidney disease risk and prognosis
Certain gene mutations affect individuals' risk of developing a serious kidney condition, as well as their prognosis after being diagnosed with the disease, according to a study appearing in an upcoming issue of the Journal of ...
Genetics
Feb 21, 2013 |
not rated yet |
0
Intravenous fluid used for critically ill patients linked with adverse outcomes
In an analysis of studies that examined critically ill patients requiring an increase in blood fluid volume, intravenous use of the fluid hydroxyethyl starch, compared with other resuscitation solutions, was not associated ...
Diseases, Conditions, Syndromes
Feb 19, 2013 |
not rated yet |
0
Synthetic marijuana use linked to kidney damage
(HealthDay)—Synthetic marijuana products, also known as Spice or K2, are potentially very dangerous for the kidneys, new research suggests.
Medications
Feb 12, 2013 |
not rated yet |
0
n-3 PUFA may reduce markers of kidney disease in T2DM
(HealthDay)—In patients with type 2 diabetes and evidence of kidney injury, supplementation with n-3 long-chain polyunsaturated fatty acids (PUFA) does not reduce urine albumin excretion but is associated ...
Diabetes
Feb 08, 2013 |
not rated yet |
0
New study identifies biomarkers for early risk assessment of acute kidney injury
Acute kidney injury strikes large numbers of hospitalized patients, including those with no prior kidney-related illness, and is one of the most costly and deadly conditions affecting critically ill patients. Findings published ...
Diseases, Conditions, Syndromes
Feb 06, 2013 |
not rated yet |
0
FDA: Samsca may cause irreversible liver damage
(HealthDay)—Patients who take Samsca (tolvaptan) may be at elevated risk for significant liver injury, according to a Jan. 25 safety alert issued by the U.S. Food and Drug Administration.
Medications
Jan 26, 2013 |
not rated yet |
0
Triple mix of blood pressure drugs and painkillers linked to kidney problems
Patients who take a triple combination of blood pressure drugs and common painkillers are at an increased risk of serious kidney problems, especially at the start of treatment, finds a study published in BMJ today.
Diseases, Conditions, Syndromes
Jan 08, 2013 |
5 / 5 (2) |
0
